If you are a participating pharmacist in this study and you have received your course training materials, please access your course HERE.
This research study is an observational post-market drug safety and effectiveness project funded by CIHR (Canadian Institutes of Health Research).
We are actively recruiting pharmacies across British Columbia to participate in this study.
There is a subpopulation of pregnant/lactating women that have hypertension and related disorders. The number is estimated to be 7-10% of the pregnant/lactating women in British Columbia. Hypertension has varying levels of severity and there isn’t a standard disease management program; rather the level of control is dependent on individual physicians’ preferences. This leaves the subpopulation exposed to different drugs and treatment programs that may be important to monitor.
Our specific goal is to demonstrate the feasibility of utilizing pharmacists to recruit pregnant and breastfeeding women into an active surveillance program of post-market drug safety and effectiveness.
The outcome will be assessed by the proportion of participants recruited through community-based pharmacies who have a hypertensive disorder with or without antihypertensive treatment. We will link the data collected with the BC Perinatal Database.
We appreciate that your pharmacy is busy and pharmacists have many responsibilities however this study requires a very small time commitment and will give your pharmacy a license to access the on-line Reprotox database.
Less than 1 in 10 pregnant and lactating women in British Columbia will meet the criteria for this study. If your pharmacy participates, you can expect to contribute no more than 3-5 hours of your pharmacists’ time to this project over 6 months.
If your pharmacy would like to participate, the following three steps are involved:
Step 1: Complementary CPPD accredited training, access to Reprotox database, and study materials are provided to all participating pharmacies.
Step 2: Pharmacy staff members will provide a letter of information, collect a consent form, and take information from any interested pregnant/lactating customers over the next 6 months. The collected forms will be faxed or mailed (in a pre-addressed ExpressPost envelope) to UBC.
Step 3: The pharmacy staff members will then follow-up with a 5 minute phone call to any patients that met the study criteria, to evaluate continued/changed anti-hypertensive drug use.
If you have any comments or questions, please contact the research coordinator, Jamie Thomas: 604-806-9099.
Your participation in this study is greatly appreciated.
Other useful websites for pharmacists participating in this study:
I am interested in participating in the study. I am at Safeway Pharmacy 0056 in Kamloops. P(250-376-9672) Please contact me at the Pharmacy for further instruction.
Thanks
Mike